Alexander Barton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Barton has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Leonard Kaps
Department of Dermatology University Medical Center Mainz Germany
3 shared publications - Christian Labenz
Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
2 shared publications - Jorn Markus Schattenberg
Department of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany
2 shared publications Christian Labenz
First Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
1 shared publicationJörn M. Schattenberg
Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany
1 shared publicationKarel Kostev
Epidemiology, IQVIA, Frankfurt am Main, Germany
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8474
Low Health Literacy in Patients with Steatotic Liver Disease and Depressive Symptoms
Background and Objectives: Health literacy (HL) affects the course of chronic diseases, yet little is known about HL in steatotic liver disease (SLD), and the role of mental comorbidities has not been examined. This study assessed HL in patients with SLD and sought to identify factors linked to lower HL. Materials and Methods: This bicentric cross-sectional study comprised 234 patients with SLD: 209 recruited prospectively in Homburg, Germany (2024–2025), and 25 patients with metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis from an existing cohort in Mainz. HL was measured with the German version of the nine-scale Health Literacy Questionnaire (HLQ). SLD was defined by a controlled attenuation parameter ≥ 275 dB/m, and advanced chronic liver disease (ACLD) by liver stiffness ≥ 15 kPa (Baveno VII/VIII) or known cirrhosis. Depressive symptoms were assessed with the Patient Health Questionnaire-9 (PHQ-9 ≥ 10; Homburg) or the Hamilton Depression Rating Scale (HDRS-17 ≥ 8; Mainz). Results: Sixty-eight patients (29%) had depressive symptoms (Homburg 25.8%, Mainz 56.0%). The groups were comparable with respect to age, sex, schooling, liver stiffness and BMI. In univariable analyses, patients with depressive symptoms had lower scores on scales 2, 3, 6 and 7. After adjustment for sex, age, BMI, schooling, and ACLD, associations remained significant for scale 2 (“Having sufficient information to manage my health”; β = −0.14, p = 0.04), scale 3 (“Actively managing my health”; β = −0.15, p = 0.02), scale 6 (“Ability to actively engage with healthcare providers”; β = −0.21, p = 0.003) and scale 7 (“Navigating the healthcare system”; β = −0.16, p = 0.02). The association with scale 6 was consistent across all sensitivity analyses, including an analysis restricted to the Homburg cohort. ACLD was not independently associated with any HLQ scale, whereas higher BMI was associated with lower scores in five of nine domains. Conclusions: More than one in four patients with SLD has depressive symptoms, which are associated with lower self-reported HL, especially regarding engagement with healthcare providers and navigation of the healthcare system. Screening for depression could help to identify patients who require additional support.
- 30 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8474
Open AccessLow Health Literacy in Patients with Steatotic Liver Disease and Depressive Symptoms
Background and Objectives: Health literacy (HL) affects the course of chronic diseases, yet little is known about HL in steatotic liver disease (SLD), and the role of mental comorbidities has not been examined. This study assessed HL in patients with SLD and sought to identify factors linked to lower HL. Materials and Methods: This bicentric cross-sectional study comprised 234 patients with SLD: 209 recruited prospectively in Homburg, Germany (2024–2025), and 25 patients with metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis from an existing cohort in Mainz. HL was measured with the German version of the nine-scale Health Literacy Questionnaire (HLQ). SLD was defined by a controlled attenuation parameter ≥ 275 dB/m, and advanced chronic liver disease (ACLD) by liver stiffness ≥ 15 kPa (Baveno VII/VIII) or known cirrhosis. Depressive symptoms were assessed with the Patient Health Questionnaire-9 (PHQ-9 ≥ 10; Homburg) or the Hamilton Depression Rating Scale (HDRS-17 ≥ 8; Mainz). Results: Sixty-eight patients (29%) had depressive symptoms (Homburg 25.8%, Mainz 56.0%). The groups were comparable with respect to age, sex, schooling, liver stiffness and BMI. In univariable analyses, patients with depressive symptoms had lower scores on scales 2, 3, 6 and 7. After adjustment for sex, age, BMI, schooling, and ACLD, associations remained significant for scale 2 (“Having sufficient information to manage my health”; β = −0.14, p = 0.04), scale 3 (“Actively managing my health”; β = −0.15, p = 0.02), scale 6 (“Ability to actively engage with healthcare providers”; β = −0.21, p = 0.003) and scale 7 (“Navigating the healthcare system”; β = −0.16, p = 0.02). The association with scale 6 was consistent across all sensitivity analyses, including an analysis restricted to the Homburg cohort. ACLD was not independently associated with any HLQ scale, whereas higher BMI was associated with lower scores in five of nine domains. Conclusions: More than one in four patients with SLD has depressive symptoms, which are associated with lower self-reported HL, especially regarding engagement with healthcare providers and navigation of the healthcare system. Screening for depression could help to identify patients who require additional support.
- Open Access
- 1 February 2026
- Published by SAGE Publications in Sage Open Chronic Disease
- Vol. 17
Inflammatory bowel disease increases the risk of liver cirrhosis: a retrospective population-based study
Introduction: Inflammatory bowel disease (IBD) incidence continues to increase in many parts of the world, especially in Asia, while the highest rates are still seen in Northern America and Europe. Data on the influence of IBD on the occurrence of liver cirrhosis are scarce. Objectives: This study investigated the impact of IBD on the incidence of liver cirrhosis in a large German primary care cohort over a 20-year timeframe. Design: Patients with IBD were matched to non-IBD individuals based on age, sex, index year, and co-diagnoses of obesity, diabetes mellitus, and alcohol addiction in a 1:5 ratio, while IBD subgroup Crohn’s disease contained 10,264 and ulcerative colitis 13,228 patients. The primary outcome of the study was the incidence of cirrhosis. Methods: The relationship between IBD and cirrhosis was investigated using univariable Cox regression analysis. Results: We compared 23,492 patients with IBD with 117,460 matched individuals without IBD. After up to 20 years of follow-up, 1.68% of patients with IBD and 0.68% of matched non-IBD patients were diagnosed with liver cirrhosis ( p = 0.001). In the total cohort, IBD was associated with an increased risk of cirrhosis (HR: 1.51; 95% CI: 1.18–1.93), while in sensitivity analyses, there was a significant association between ulcerative colitis and development of liver cirrhosis (HR: 1.59; 95% CI: 1.16–2.18), while there was no significant association between Crohn’s disease and liver cirrhosis. The association was stronger and statistically significant in individuals aged ⩾ 50 years (HR: 1.56; 95% CI: 1.19–2.04), but not in younger individuals. A more pronounced risk was observed in women (HR: 1.83; 95% CI: 1.28–2.62) compared to men (HR: 1.29; not significant). Conclusion: In conclusion, IBD is associated with an increased risk of a cirrhosis diagnosis, with older patients appearing to be particularly vulnerable.
- 1 February 2026
- Published by SAGE Publications in Sage Open Chronic Disease
- Vol. 17
Open AccessInflammatory bowel disease increases the risk of liver cirrhosis: a retrospective population-based study
Introduction: Inflammatory bowel disease (IBD) incidence continues to increase in many parts of the world, especially in Asia, while the highest rates are still seen in Northern America and Europe. Data on the influence of IBD on the occurrence of liver cirrhosis are scarce. Objectives: This study investigated the impact of IBD on the incidence of liver cirrhosis in a large German primary care cohort over a 20-year timeframe. Design: Patients with IBD were matched to non-IBD individuals based on age, sex, index year, and co-diagnoses of obesity, diabetes mellitus, and alcohol addiction in a 1:5 ratio, while IBD subgroup Crohn’s disease contained 10,264 and ulcerative colitis 13,228 patients. The primary outcome of the study was the incidence of cirrhosis. Methods: The relationship between IBD and cirrhosis was investigated using univariable Cox regression analysis. Results: We compared 23,492 patients with IBD with 117,460 matched individuals without IBD. After up to 20 years of follow-up, 1.68% of patients with IBD and 0.68% of matched non-IBD patients were diagnosed with liver cirrhosis ( p = 0.001). In the total cohort, IBD was associated with an increased risk of cirrhosis (HR: 1.51; 95% CI: 1.18–1.93), while in sensitivity analyses, there was a significant association between ulcerative colitis and development of liver cirrhosis (HR: 1.59; 95% CI: 1.16–2.18), while there was no significant association between Crohn’s disease and liver cirrhosis. The association was stronger and statistically significant in individuals aged ⩾ 50 years (HR: 1.56; 95% CI: 1.19–2.04), but not in younger individuals. A more pronounced risk was observed in women (HR: 1.83; 95% CI: 1.28–2.62) compared to men (HR: 1.29; not significant). Conclusion: In conclusion, IBD is associated with an increased risk of a cirrhosis diagnosis, with older patients appearing to be particularly vulnerable.
- Open Access
- 31 January 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 65
Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis
Background/Objectives: The incidence of inflammatory bowel disease (IBD) is rising worldwide, particularly in Asia, while the highest prevalence remains in North America and Europe. Evidence on the relationship between IBD and the development of autoimmune thyroiditis is limited. This study investigated the association between IBD and a subsequent autoimmune thyroiditis in a large German primary care cohort over a 10-year period. Methods: Patients with IBD were propensity score matched to non-IBD individuals in a 1:5 ratio based on age, sex, index year, and average annual number of physician visits during follow-up. A total of 20,084 IBD patients—including 8791 with Crohn’s disease and 11,293 with ulcerative colitis—and 100,420 matched controls were included. The primary outcome was the cumulative incidence of autoimmune thyroiditis, including Hashimoto’s thyroiditis and Graves’ disease. The association between IBD and autoimmune thyroiditis was evaluated using univariable conditional Cox regression analysis. Results: In the overall cohort, no significant association was found between IBD (Crohn’s disease or ulcerative colitis) and autoimmune thyroiditis (Hashimoto’s or Graves’ disease). However, among patients aged ≥ 65 years, IBD was associated with a significantly increased risk of Graves’ disease (HR 2.83; 95% CI 1.56–5.15), an effect observed in both Crohn’s disease (HR 3.23; 95% CI 1.20–8.69) and ulcerative colitis (HR 2.64; 95% CI 1.25–5.60). Conclusions: While IBD was not associated with autoimmune thyroiditis overall, a significant positive association with Graves’ disease was observed among patients aged ≥ 65 years, highlighting the importance of age-specific risk assessment.
- 31 January 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 65
Open AccessInflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis
Background/Objectives: The incidence of inflammatory bowel disease (IBD) is rising worldwide, particularly in Asia, while the highest prevalence remains in North America and Europe. Evidence on the relationship between IBD and the development of autoimmune thyroiditis is limited. This study investigated the association between IBD and a subsequent autoimmune thyroiditis in a large German primary care cohort over a 10-year period. Methods: Patients with IBD were propensity score matched to non-IBD individuals in a 1:5 ratio based on age, sex, index year, and average annual number of physician visits during follow-up. A total of 20,084 IBD patients—including 8791 with Crohn’s disease and 11,293 with ulcerative colitis—and 100,420 matched controls were included. The primary outcome was the cumulative incidence of autoimmune thyroiditis, including Hashimoto’s thyroiditis and Graves’ disease. The association between IBD and autoimmune thyroiditis was evaluated using univariable conditional Cox regression analysis. Results: In the overall cohort, no significant association was found between IBD (Crohn’s disease or ulcerative colitis) and autoimmune thyroiditis (Hashimoto’s or Graves’ disease). However, among patients aged ≥ 65 years, IBD was associated with a significantly increased risk of Graves’ disease (HR 2.83; 95% CI 1.56–5.15), an effect observed in both Crohn’s disease (HR 3.23; 95% CI 1.20–8.69) and ulcerative colitis (HR 2.64; 95% CI 1.25–5.60). Conclusions: While IBD was not associated with autoimmune thyroiditis overall, a significant positive association with Graves’ disease was observed among patients aged ≥ 65 years, highlighting the importance of age-specific risk assessment.